Skip to content
Find a Provider
Emily DiCesare, D.O.

Emily DiCesare, D.O.

Emergency Medicine

No ratings currently available, see text in Ratings section below for explanation.

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Not Accepting New Patients

Contact

Appointment (585) 341-6880

About Me

Dr. DiCesare is an assistant professor of Emergency Medicine. She obtained her undergraduate degree from Elmira College in 2002, and her Masters in Molecular Biology from New York University in 2005. She received her medical degree from Lake Erie College of Osteopathic Medicine in 2009. Dr. DiCesare...
Dr. DiCesare is an assistant professor of Emergency Medicine. She obtained her undergraduate degree from Elmira College in 2002, and her Masters in Molecular Biology from New York University in 2005. She received her medical degree from Lake Erie College of Osteopathic Medicine in 2009. Dr. DiCesare completed her residency at the University of Rochester in 2012, and served as Chief Resident from 2011-2012.

Certified Specialties

Emergency Medicine - American Board of Emergency Medicine

Faculty Appointments

Assistant Professor of Clinical Emergency Medicine (Part-Time) - Department of Emergency Medicine, Highland (SMD)

Credentials

Residency & Fellowship

Internship, Emergency Medicine, University of Rochester Medical Center. 2009 - 2010

Residency, Emergency Medicine, University of Rochester Medical Center. 2009 - 2012

Education

DO | Lake Erie College of Osteopathic Medicine. 2009

Publications

Journal Articles

The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide.

O'Connor OA, Smith EA, Toner LE, Teruya-Feldstein J, Frankel S, Rolfe M, Wei X, Liu S, Marcucci G, Chan KK, Chanan-Khan A

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2006 May 112 (9):2902-11. Epub 1900 01 01.

Sequencing of The Novel antifolate 10-propargyl-10-deaxaaminopterin (PDX) and Gemcitabine induces apoptosis and is markedly superior to Methotrexate (MTX) and cytarabine in murine xenograft models of human aggressive non-Hodgkin's lymphoma.

O'Connor, O.A.; Toner, L.; Smith, E.; Vrhoec, R.;.

Clinical Cancer Research. 2006; 12: 924-932.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.